Literature DB >> 24024789

How to diagnose amyloidosis.

P Mollee1, P Renaut, D Gottlieb, H Goodman.   

Abstract

Amyloidosis is a rare but devastating condition caused by deposition of misfolded proteins as aggregates in the extracellular tissues of the body, leading to impairment of organ function. High clinical suspicion is required to facilitate early diagnosis. Correct identification of the causal amyloid protein is absolutely crucial for clinical management in order to avoid misdiagnosis and inappropriate, potentially harmful treatment, to assess prognosis, and to offer genetic counselling if relevant. This review summarises the current evidence on which the diagnosis and subtyping of amyloidosis is based, outlines the limitations of various diagnostic techniques, particularly in an Australian and New Zealand context, and discusses optimal strategies for the diagnostic approach to these patients. Recommendations are provided for when particularly to suspect amyloidosis, what investigations are required, as well as an approach to accurate subtyping of amyloidosis.
© 2013 The Authors; Internal Medicine Journal © 2013 Royal Australasian College of Physicians.

Entities:  

Keywords:  amyloidosis; diagnosis; genetic testing; immunohistochemistry; proteomics

Mesh:

Substances:

Year:  2014        PMID: 24024789     DOI: 10.1111/imj.12288

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  24 in total

1.  First case of pleural amyloidosis in systemic erythematosus: report and literature review.

Authors:  J Xiong; Y Ren; H Li; B Fu; R Wu
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

Review 2.  Pathophysiology and treatment of cardiac amyloidosis.

Authors:  Morie A Gertz; Angela Dispenzieri; Taimur Sher
Journal:  Nat Rev Cardiol       Date:  2014-10-14       Impact factor: 32.419

Review 3.  Fibrinogen alpha amyloidosis: insights from proteomics.

Authors:  Jessica Chapman; Ahmet Dogan
Journal:  Expert Rev Proteomics       Date:  2019-08-28       Impact factor: 3.940

Review 4.  Approach to the Diagnosis of Amyloidosis.

Authors:  Richa Juneja; H P Pati
Journal:  Indian J Hematol Blood Transfus       Date:  2019-10-09       Impact factor: 0.900

5.  A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis.

Authors:  Taro Murakami; Akira Takasawa; Asako Moriki; Yusuke Igaki; Hiroshi Ikeda; Kazuyuki Murase; Kohichi Takada; Kazufumi Magara; Tomoyuki Aoyama; Yusuke Ono; Daisuke Kyuno; Kumi Takasawa; Masaki Murata; Makoto Osanai
Journal:  Virchows Arch       Date:  2021-03-10       Impact factor: 4.064

6.  Deep-learning-based cardiac amyloidosis classification from early acquired pet images.

Authors:  Maria Filomena Santarelli; Dario Genovesi; Vincenzo Positano; Michele Scipioni; Giuseppe Vergaro; Brunella Favilli; Assuero Giorgetti; Michele Emdin; Luigi Landini; Paolo Marzullo
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-16       Impact factor: 2.357

Review 7.  Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure with Preserved Ejection Fraction.

Authors:  Evandro Tinoco Mesquita; Antonio José Lagoeiro Jorge; Celso Vale Souza; Thais Ribeiro de Andrade
Journal:  Arq Bras Cardiol       Date:  2017-06-29       Impact factor: 2.000

8.  Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7.

Authors:  Jessica R Chapman; Anna Liu; San S Yi; Enmily Hernandez; Maria Stella Ritorto; Achim A Jungbluth; Melissa Pulitzer; Ahmet Dogan
Journal:  Amyloid       Date:  2020-09-01       Impact factor: 7.141

9.  Cardiac Amyloidosis-Challenging Diagnosis and Unclear Clinical Picture.

Authors:  Sylwia Kozak; Krzysztof Ulbrich; Maciej Migacz; Krzysztof Szydło; Katarzyna Mizia-Stec; Michał Holecki
Journal:  Medicina (Kaunas)       Date:  2021-05-06       Impact factor: 2.430

10.  Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis.

Authors:  Ali M Agha; Nicolas Palaskas; Amit R Patel; Jeanne DeCara; Purvi Parwani; Cezar Iliescu; Jean B Durand; Peter Kim; Saamir Hassan; Gregory Gladish; Hans C Lee; Gregory P Kaufman; Juan C Lopez-Mattei
Journal:  Front Cardiovasc Med       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.